Health
This is to provide Latest HealthNews around the globe
-
Woman loses weight with Ozempic only to lose insurance coverage for the drug
WAUSAU, Wis. (WSAW) – Ozempic, Mounjaro, Wegovy. Those medications seem to be everywhere right now. In our new series, ‘A New Weigh of Life,’ NewsChannel7 will share the weight loss journey of three people and what GLP-1s do to the body. How GLP-1s affect the body: The medications mimic a hormone our body makes naturally called Glucagon-Like Peptide 1, or…
Read More » -
Former assistant director at Department of Health and Human Services convicted of embezzling $100K
SPOKANE, Wash. (Gray news) – A former assistant director at the Department of Health and Human Services was convicted of bank fraud and embezzlement of $100,000 during her employment, according to the Department of Justice. In a release, United States Attorney Pete Serrano said Tawhnee Willow Colvin was convicted of 25 counts of bank fraud and one count of embezzlement…
Read More » -
Meet the company making GLP-1 medication more affordable
Meet the program trimming pounds and prices. Ozempic has delivered impressive results for millions of Americans, but not everyone can stomach the cost of popular weight loss drugs. Depending on a patient’s location, insurance coverage and dosage, a monthly supply of semaglutide can cost up to $1200 a month. And, for many people, the steep price tag isn’t the only…
Read More » -
UCLA to co-lead a large-scale randomized trial of AI in breast cancer screening
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: UCLA and UC Davis will co-lead a newly funded, multi-institutional clinical trial to evaluate whether artificial intelligence (AI) can help support radiologists in interpreting mammograms more accurately, with the goal of improving breast cancer screening and…
Read More » -
Multi-registry study highlights ocrelizumab’s superior relapse control in multiple sclerosis
Credit: Unsplash/CC0 Public Domain New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, was evaluated using real-world data from three large MS registries: MSBase,…
Read More » -
White House weighs creating ‘TrumpRx’ website where citizens can buy meds directly from pharma companies: report
The Trump administration is considering setting up a government-run website that would help Americans buy cheaper medications directly from pharmaceutical companies, according to reports. Inside sources told Bloomberg News that the website would let users search for specific drugs and then connect them with manufacturers, allowing them to pay out of pocket at a discounted price. One name reportedly being…
Read More » -
The common herb that fights bacteria and tames stress
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know…
Read More » -
World health experts reject Trump and RFK Jr.’s claims about Tylenol, autism link
Health experts from around the globe are joining the chorus of doctors and organizations pushing back against the Trump administration’s announcement Monday linking the use of acetaminophen — the active ingredient in Tylenol and many cold and flu medications — during pregnancy to an increased risk of autism in children. “Effective immediately, the FDA will be notifying physicians that the use…
Read More » -
Molecular breast imaging increases overall invasive cancer detection in women with dense breasts
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate compared with screening only with DBT, according to a…
Read More » -
Cardiovascular–kidney–metabolic syndrome may shorten your life expectancy
Reduction in life expectancy by CKM status for male and female. Credit: PLOS Medicine (2025). DOI: 10.1371/journal.pmed.1004629 A study involving more than half a million adults has confirmed that the combination of cardiovascular, kidney, and metabolic conditions, collectively known as cardiovascular–kidney–metabolic (CKM) syndrome, substantially increases the risk of early death and serious illness. The findings highlight the urgent need for…
Read More »
